1. Nathan, P. J. . Hypericum Perforatum (St John's Wort): A Non-Selective Reuptake Inhibitor? A Review of the Recent Advances in Its Pharmacology. Journal Psychopharmacology, 2001. 1, 47-54. doi:10.1177/026988110101500109
2. Karliova, M., Treichel, U., Malago, M., Frilling, A., Gerken, G., & Broelsch, C. E. Interaction of Hypericum Perforatum (St. John's Wort) With Cyclosporin A Metabolism in a Patient After Liver Transplantation. Journal Hepatology, 2000. 5, 853-855. doi:10.1016/s0168-8278(00)80321-9.
3. Ruschitzka, F., Meier, P. J., Turina, M., Luscher, T. F., & Noll, G. Acute Heart Transplant Rejection Due to Saint John's Wort. Lancet, 2000. 355(9203), 548-549. doi:10.1016/S0140-6736(99)05467-7.
4. Nicolussi, S., Drewe, J., Butterweck, V., & Schwabedissen, H. E. Clinical relevance of St. John's wort drug interactions revisited. British Journal of Pharmacology, 2020. 1212-1226.
5. Schwarz, U. I., Buschel, B., & Kirch, W. Unwanted pregnancy on self‐medication with St John's wort despite hormonal contraception. British Journal of Clinical Pharmacology, 2003. 55, 112-113. doi:10.1046/j.1365-2125.2003.01716.x
6. Muller, S. C., Majcher-Peszynska, J., Uehleke, B., et al. The Extent of Induction of CYP3A by St. John's Wort Varies Among Products and Is Linked to Hyperforin Dose. Europe Journal Clinical Pharmacology, 2006. 62(1), 29-36. doi:10.1007/s00228-005-0061-3. Epub 2005
7. Zahner, C., Kruttschnitt, E., Uricher, J., Lissy, M., Hirsch, M., Nicolussi, S., Drewe, J. No Clinically Relevant Interactions of St. John's Wort Extract Ze 117 Low in Hyperforin With Cytochrome P450 Enzymes and P-glycoprotein. Clinical Pharmacology Therapy, 2019. 106(2), 432-440. doi:10.1002/cpt.1392
8. Tachijan, A., Maria, V., & Jahangir, A. Use of Herbal Products and Potential Interactions in Patients With Cardiovascular Diseases. J Am Coll Cardiol, 2010. 55(6), 515-525. doi:10.1016/j.jacc.2009.07.074
9. Piscitelli, S. C., Burstein, A. H., Chaitt, D., Alfaro, R. M., & Falloon, J. Indinavir Concentrations and St John's Wort. Lancet, 2000. 547-548. doi:10.1016/S0140-6736(99)05712-8.
10. Strater, A. v., & Bogers, J. P. Interaction of St John's wort (Hypericum perforatum) with clozapine. International clinical psychopharmacology, 2011. 27(2), 121-124. doi:10.1097/YIC.0b013e32834e8afd
11. Borrelli, F., & Izzo, A. A. Herb–Drug Interactions with St John’s Wort (Hypericum perforatum): an Update on Clinical Observations. The AAPS Journal, 2009. 11(4), 710. doi:10.1208/s12248-009-9146-8
12. Murphy, P. A. St. John's Wort and Oral Contraceptives: Reasons for Concern? Journal Midwifery Womens Health, 2002. 47(6), 447-450. doi:10.1016/s1526-9523(02)00321-5
13. Nieminen, T. H., Hagelberg, N. M., Saari, T. I., Neuvonen, M., Laine, K., Neuvonen, P. J., & Olkkola, K. T. St John’s wort greatly reduces the concentrations of oral oxycodone. European Journal of Pain, 2010. 14(8), 854-859. doi:doi.org/10.1016/j.ejpain.2009.12.007
14. Dombrowski, S., & Ferro, L. ASHP Therapeutic Position Statement on the Safe Use of Pharmacotherapy for Obesity Management in Adults . American Journal of Health System Pharmacy, 2001. 58(17), 613-627.
15. Hebert, M. F., Park, J. M., Chen, Y. L., Akhtar, S., & Larson, A. M. Effects of St. John's Wort (Hypericum Perforatum) on Tacrolimus Pharmacokinetics in Healthy Volunteers. J Clin Pharmacol, 2004. 44(1), 89-94. doi:10.1177/0091270003261078
16. Assalian, P. Sildenafil for St. John WortInduced Sexual Dysfunction. Journal of Sex and Marital Therapy, 2000. 26(4), 357-358. doi:10.1080/009262300438788
17. Takeshita, J., & Litzinger, M. H. Serotonin Syndrome Associated With Tramadol. The Primary Care Companion to the Journal of Clinical Psychiatry, 2009. 11(5), 273. doi:10.4088/PCC.08l00690
18. Dougherty, J. A., Young, H., & Shafi, T. Serotonin Syndrome Induced by Amitriptyline, Meperidine, and Venlafaxine. Ann Pharmacother, 2002. 36(10), 1647-1648. doi:10.1345/aph.1C091